A reverse translational study on the effect of rituximab, rituximab plus belimumab, or bortezomib on the humoral autoimmune response in SLE

OBJECTIVES: SLE is a severe autoimmune disease characterized by autoreactive B cells and IC formation, which causes systemic inflammation. B cell–targeted therapy could be a promising treatment strategy in SLE patients; nevertheless, randomized clinical trials have not always been successful. Howeve...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Rheumatology (Oxford)
Main Authors: van Dam, Laura S, Osmani, Zgjim, Kamerling, Sylvia W A, Kraaij, Tineke, Bakker, Jaap A  , Scherer, Hans U, Rabelink, Ton J, Voll, Reinhard E, Alexander, Tobias, Isenberg, David A, van Kooten, Cees, Teng, Y K Onno
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Clinical Science
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7516125/
https://ncbi.nlm.nih.gov/pubmed/31951278
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/kez623
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados